The firms will validate histopathology biomarkers related to bladder cancer using clinical data and tissue samples captured during cystoscopy.

Natera said the Food and Drug Administration approved its Signatera CDx as a test for bladder cancer. The drug can be used as a companion diagnostic with adjuvant atezolizumab to treat muscle-invasive ...

Solidifies Natera’s Treatment on MRD (TOMR) approach as the new standard of care in MIBC, enabling precision interventions for MRD-positive patients while sparing MRD-negative patients from ...

Marks the first Medicare coverage decision for Veracyte’s whole-genome sequencing-based TrueMRD platform and launch of the first test Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics ...

Valar Labs has been awarded breakthrough device designation for the Vesta Bladder Risk Stratify Dx, an AI-powered digital pathology prognostic test in bladder cancer. The Palo Alto, CA-based company ...

“There’s almost this disbelief that washes over you, like your brain can’t fully process what it’s being told," James “Jimi” Stewart said of his diagnosis Jimi Stewart A seemingly healthy 39-year-old ...

Bladder exstrophy complex is a congenital anomaly characterised by eversion of the bladder through a defect in the lower abdominal wall, accompanied by varying degrees of pelvic bone separation, ...

Share on Pinterest A new urine test may enable more personalized treatment for bladder cancer. Image credit: SolStock/Getty Images A new urine-based test can detect minimal residual bladder cancer ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...

The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...

When dealing with bulk quantities of used iPhones, surface appearance alone does not guarantee the internal quality. Small flaws usually go unnoticed in the background, affecting the resale value and ...

Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...